Video

Casgevy Approval Retrospective With Lina Jamis

Learn more about the groundbreaking approval of the US' first CRISPR therapy by Vertex Pharmaceuticals and CRISPR Therapeutics, and how it's reshaping the landscape of CRISPR regulations and ongoing clinical trials. In this insightful video, Lina Jamis, Associate Director of Regulatory Affairs at Synthego, shares key learnings and valuable perspectives on the latest developments in the field of CRISPR therapeutics. Stay informed and gain valuable insights into the future of CRISPR therapies.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Synthego Corporation